Sign in

William McNarland

Research Analyst at TDR Research

William McNarland is an Equity Analyst at TDR Research, specializing in cannabis industry equities with focused coverage on companies such as MariMed Inc. His analyst performance data is limited in the public domain, but he has participated in at least one official earnings call, demonstrating direct industry engagement. Earlier details about McNarland’s broader career trajectory, previous firms, or professional credentials such as securities licenses or FINRA registration are not presently available. His public research record reflects a narrow specialization with an emphasis on cannabis sector analysis.

William McNarland's questions to MARIMED (MRMD) leadership

William McNarland's questions to MARIMED (MRMD) leadership • Q3 2024

Question

William McNarland from TDR Research noted that his questions regarding the M&A pipeline and margin improvements had already been addressed by previous analysts.

Answer

The analyst indicated his questions on the M&A pipeline and margin improvements were previously covered, so no new response was provided by management.

Ask Fintool Equity Research AI